JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 40 No. 7 1091-1097
© 1999 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Habraken, J. B.A.
Right arrow Articles by van Royen, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Habraken, J. B.A.
Right arrow Articles by van Royen, E. A.

Quantification and Visualization of Defects of the Functional Dopaminergic System Using an Automatic Algorithm

Jan B.A. Habraken, Jan Booij, Piotr Slomka, Ellinor Busemann Sokole and Eric A. van Royen

Graduate School of Neurosciences Amsterdam, Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Department of Diagnostic Radiology and Nuclear Medicine, University of Western Ontario and Victoria Hospital, London, Ontario, Canada

Correspondence: For correspondence or reprints contact: Jan B.A. Habraken, MSc, Department of Nuclear Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

ABSTRACT

In SPECT, the binding of radiotracers in brain areas is usually assessed by manual positioning of regions of interest (ROIs). The disadvantages of this method are that it is an observer-dependent procedure and that it may not be sensitive for assessing defects significantly smaller than the ROI. To circumvent these limitations, we developed a fully automatic three-dimensional technique that quantifies neuronal radiotracer binding on a voxel-by-voxel basis. Methods: To build a model of normal 123I-labeled N-{omega}-fluoropropyl-2ß-carbomethoxy-3ß-(4-iodophenyl)nortropane (FPCIT) binding, 17 studies of healthy volunteers were registered to the same orientation. After registration, the specific-to-nonspecific binding ratio was calculated for each voxel of the striatal volumes of interest (VOIs). The mean and SD of that binding ratio were then calculated on a voxel-by-voxel basis. For the analysis of 10 healthy volunteer studies (control group) and 21 studies of drug-naive patients with Parkinson's disease, the registration and calculation of the specific-to-nonspecific [123I]FPCIT binding ratio were performed by the same method. Subsequently, a voxel of the striata was classified as a diminished [123I]FPCIT binding ratio if its value was lower than the mean –2 x SD. For each subject, the defect size, the relative number of voxels with a diminished binding ratio and the binding ratio of the whole striatal VOIs were calculated and compared with the binding ratio as assessed by the traditional ROI method. Results: The results of the automatic method correlated significantly with the results of the traditional ROI method. Furthermore, for the ipsilateral side, the automatically calculated defect size had less overlap between the patient and the control group than the traditionally calculated binding ratio. Conclusion: The method presented quantifies [123I]FPCIT binding ratio automatically on a voxel-by-voxel basis, by comparison with a model of healthy volunteers. We have shown that it is appropriate to use the automatic method as a replacement for the traditional manual method, which enables us to study the localized dopaminergic degeneration process in Parkinson's disease more precisely and without any inter- or intraobserver variability.

Key Words: 123I-labeled N-{omega}-fluoropropyl-2ß-carbomethoxy-3ß-(4-iodophenyl)nortropane • SPECT • three-dimensional • automatic quantification




This article has been cited by other articles:


Home page
J Geriatr Psychiatry NeurolHome page
S. Colloby and J. O'Brien
Functional Imaging in Parkinson's Disease and Dementia with Lewy Bodies
J Geriatr Psychiatry Neurol, September 1, 2004; 17(3): 158 - 163.
[Abstract] [PDF]


Home page
JNMHome page
W. Robeson, V. Dhawan, A. Belakhlef, Y. Ma, V. Pillai, T. Chaly, C. Margouleff, D. Bjelke, and D. Eidelberg
Dosimetry of the Dopamine Transporter Radioligand 18F-FPCIT in Human Subjects
J. Nucl. Med., June 1, 2003; 44(6): 961 - 966.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. Van Laere, M. Koole, Y. D’Asseler, J. Versijpt, K. Audenaert, F. Dumont, and R. Dierckx
Automated Stereotactic Standardization of Brain SPECT Receptor Data Using Single-Photon Transmission Images
J. Nucl. Med., February 1, 2001; 42(2): 361 - 375.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1999 by the Society of Nuclear Medicine.